Sernova (TSE:SVA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sernova Corp., a clinical-stage biotech leader in cell therapeutics, is set to participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York, including one-on-one investor meetings. The company is advancing its Cell Pouch System, a device aimed at providing a ‘functional cure’ for insulin-dependent diabetes and other chronic diseases, with promising results in a clinical study.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
